Ireland
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 9.19 B
|
Oct. 25, 2024 | USD 85.25 | 4.23% |
|
Ireland |
|
2 |
USD 2.42 B
|
March 31, 2024 | USD 42.18 | 0.76% |
|
Ireland |
|
3 |
USD 1.52 B
|
Dec. 31, 2023 | USD 200.24 | -8.14% |
|
Ireland |
|
4 |
USD 1.34 B
|
Sept. 30, 2024 | USD 207.57 | 0.10% |
|
Ireland |
|
5 |
USD 1.32 B
|
Dec. 31, 2023 | USD 93.99 | 0.60% |
|
Ireland |
|
6 |
USD 1.23 B
|
Dec. 31, 2023 | USD 122.96 | -0.16% |
|
Ireland |
|
7 |
USD 519.48 M
|
Dec. 31, 2023 | USD 28.50 | 0.53% |
|
Ireland |
|
8 |
USD 121.84 M
|
Dec. 31, 2023 | USD 2.05 | 2.67% |
|
Ireland |
|
9 |
USD 21.74 M
|
Dec. 31, 2023 | USD 69.11 | -2.10% |
|
Ireland |
|
10 |
USD -605.96 K
|
Dec. 31, 2023 | USD 0.02 | -6.17% |
|
Ireland |
|
11 |
USD -34.58 M
|
Dec. 31, 2023 | USD 1.60 | -2.44% |
|
Ireland |
|
12 |
USD -41.15 M
|
Dec. 31, 2023 | USD 8.19 | -1.92% |
|
Ireland |
|
13 |
USD -149.12 M
|
Dec. 31, 2023 | USD 8.05 | 2.94% |
|
Ireland |
|
14 |
USD -190.11 M
|
Dec. 31, 2023 | USD 12.67 | -3.50% |
|
Ireland |
|
15 |
USD -192.72 M
|
Dec. 31, 2023 | USD 3.72 | -0.53% |
|
Ireland |
The Pharmaceuticals company in Ireland with the highest EBITDA is Medtronic plc (NYSE: MDT) at USD 9.19 B.
The Pharmaceuticals company in Ireland with the lowest EBITDA is Mural Oncology plc (NasdaqGM: MURA) at USD -192.72 M.
The top 10 Pharmaceuticals companies in Ireland by EBITDA are Medtronic plc, Experian plc, ICON Public Limited Company, STERIS plc, Kerry Group plc, Jazz Pharmaceuticals plc, Alkermes plc, Uniphar plc, Cosmo Pharmaceuticals N.V. and Ovoca Bio plc.
The bottom 10 Pharmaceuticals companies in Ireland by EBITDA are Mural Oncology plc, Prothena Corporation plc, Avadel Pharmaceuticals plc, GH Research PLC, Iterum Therapeutics plc, Ovoca Bio plc, Cosmo Pharmaceuticals N.V., Uniphar plc, Alkermes plc and Jazz Pharmaceuticals plc.